7th Annual Developing IP Strategies for Crystalline Forms

Event details

24th - 26th October 2011


About the event

Confirmed speakers:

Paul Fehlner, Global Head, Pharma Intellectual Property, Novartis
Eric Ruhlmann, European Patent Attorney, Actelion
Nicolas Ruiz, Head of IP, Esteve
Andre Bourgouin, Chief IP Officer, Ipsen
Raymond Parker, Assistant General Counsel, Vice President of Patents, Aptalis Pharmaceuticals
Richie Paul, Head of IP, Elan Drug Technologies
Bertrand Gellie, Director, European Patent Office
Andrew Bartlett, Deputy Director, Intellectual Property Office
James Smith, Chief of Board of Patent Appeals and Interferences, USPTO
Chris Hayes, Senior Advisor, Intellectual Property Rights - Launched Products, Lundbeck
Bo Hammer Janssen, Senior Patent Counsel, Novozymes
Mandar Kodgule, Head Intellectual Property and Strategic Planning, Wockhardt
James Horgan, Assistant Counsel, Merck
Dr Avajit Kelka, Director, Head IP Management Cell, API and Generics, Dr Reddys Laboratories (UK)
Alastair Wilson QC, Joint Head of Chambers, Hogarth Chambers
Professor Christian Lehmann, Head of Chemical Crystallography and Electron Mictroscopy, Max-Planck Institute
Professor Sally Price, Professor of Physical Chemistry, University College London
Ellen Setreus, European Patent Attorney, Valea AB